Radiation is an integral component of the treatment of small cell lung cancer, as a definitive treatment for limited stage disease, as prophylactic cranial irradiation for prevention of brain metastases, as consolidation to the chest in extensive stage disease, and for palliation.

The prediction of treatment outcomes for individual patients or patient populations, including tumor control and normal tissue toxicity, has always been of tremendous importance for driving clinical practice in Radiation Oncology and at the same time has been an active area within the research co

The course has two components. First, the moderator leads a discussion among the panelists of pre-selected difficult cases.

This course presents challenging cases of women with cervix cancer, either due to poorly studied disease subsets (e.g.

Immunotherapy has been rapidly integrated into oncology practice across multiple disease types.

In this course, a multidisciplinary, multi-institutional group of experts will provide brief updates as to the latest techniques, approaches, outcomes, and toxicities of their modality in the treatment of patients with newly diagnosed oral cavity, larynx, and hypopharynx cancers.

The course begins with case studies involving suboptimal multidisciplinary care, which translates into detrimental effects for the patients involved.

Prognostication is one of the most difficult tasks that radiation oncologists face. Traditionally, patients with metastatic cancer have had poor life expectancies on the order of weeks to months.

This course reviews the treatment guidelines for children with the most common benign and malignant tumors of childhood, with a focus on radiotherapy. Indications for radiotherapy are discussed, in addition to radiotherapy planning guidelines.